Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan

Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan

Abstract Background Bronchopulmonary dysplasia (BPD) is the most common complication of preterm birth with short-term and long-term adverse consequences. Although the glucocorticoid dexamethasone has been proven to be beneficial for the prevention of BPD, there are concerns about an increased risk o...

Full description

Bibliographic Details
Main Authors: Wes Onland, Maruschka P. Merkus, Debbie H. Nuytemans, Marijke C. Jansen-van der Weide, Rebecca Holman, Anton H. van Kaam, on behalf of the SToP-BPD study group
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Trials
Subjects:
Hydrocortisone
Preterm
Mortality
Bronchopulmonary dysplasia
Statistical analysis plan
Online Access:http://link.springer.com/article/10.1186/s13063-018-2505-y

Internet

http://link.springer.com/article/10.1186/s13063-018-2505-y

Similar Items